Ergomed PLC's (LON:ERGO) Richard Barfield talks to Proactive London's Katie Pilbeam about their audited full year results for the year which ended 31 December 2020. Barfield talks through the details which include adjusted EBITDA £19.4 million, up 55.2%, and revenue of £86.4 million, up 26.5%.
He goes on to explain the reasons behind these numbers, with strategic acquisitions in CRO and pharmacovigilance in the US.